All In MedTech

Device Trial Radar · NCT03320863

The Enso Study for Chronic Low Back Pain

A Multicenter Randomized Controlled Clinical Trial Evaluating the Effectiveness of a Novel Form of Non-Invasive Neuromodulation for Treatment of Chronic Low Back Pain

Last checked: Nov 19, 2026Latest source record: Jan 27, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

50

Planned (sponsor's estimate)

Start

Nov 9, 2017

Primary completion

Dec 30, 2020

Study completion Jan 30, 2021

Sponsor

Lead sponsor
Thimble Bioelectronics, Inc.Not on our public-company list
Sponsor type
Industry
Collaborators
University of California, San Francisco
First posted
Oct 25, 2017

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Enso is a portable device for the treatment of chronic and acute types of musculoskeletal pain. This study is being designed as a double-blinded, sham-controlled randomized clinical trial.

Conditions

  • Chronic Low Back Pain

Interventions

  • Enso deviceDevice

    An active Enso device that delivers neuromodulation therapy.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Six Minute Walk TestTime frame: Once a week for 4 weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • University of California Medical Center

    San Francisco, California · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.